Position in IMCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,459,674
+$166,782 QoQ
Shares Held
45,974
+7.2% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. IMCR ranks #299 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,459,674 | 45,974 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,292,892 | 42,882 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,493,432 | 43,026 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,670,053 | 45,969 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,631,791 | 52,001 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,101,469 | 37,124 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,047,014 | 35,492 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,091,791 | 35,072 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,190,962 | 35,142 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,757,925 | 27,045 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,778,301 | 26,029 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,265,841 | 24,390 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,040,066 | 17,346 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $714,803 | 14,458 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $825,118 | 14,458 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $772,820 | 16,464 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $614,271 | 16,464 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $283,302 | 9,475 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $205,337 | 5,997 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $222,308 | 5,997 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $234,182 | 5,997 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||